DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.DaVita Inc. (DVA) shares fell 2.19% to $232.08 on Wednesday, underperforming competitors like UnitedHealth Group and Quest Diagnostics during a broadly weak market session. The stock closed 3.15% below its 52-week high of $239.64. Trading volume reached 979,314, exceeding the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DaVita Inc. (DVA) slid 2.19% to $232.08 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.14% to 7,498.96 and Dow Jones Industrial Average falling 0.01% to 52,218.58.
DaVita Inc. closed 3.15% short of its 52-week high of $239.64, which the company reached on July 7th.
The stock underperformed when compared to some of its competitors Wednesday, as UnitedHealth Group Inc. (UNH) fell 1.16% to $431.31, Icon PLC (ICLR) rose 0.40% to $167.28, and Quest Diagnostics Inc. (DGX) rose 1.45% to $209.83.
Trading volume (979,314) eclipsed its 50-day average volume of 824,614.
Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-22-26 1711ET